Aurobindo Pharma USA, Inc. recalls Aurobindo — Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP, Valsartan Tablets USP
- Recall date
- December 31, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Aurobindo Pharma USA, Inc., Aurobindo
Why it was recalled
Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Lack of Sterility
What was recalled
Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP, Valsartan Tablets USP
Read the official recall notice →
Get recall alerts
Free email alert whenever Aurobindo Pharma USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma USA, Inc., Aurobindo